⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider
globenewswire.com
NVS
LLY
Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program
businesswire.com
NVS
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
globenewswire.com
NVS
Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
globenewswire.com
NVS
LLY
BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair
globenewswire.com
PFE
NVS
Bringing His On-Screen Journey to Life, Ricco Ross of Tyler Perry's Netflix Series 'Beauty in Black' Joins ZERO Prostate Cancer as Global Ambassador
prnewswire.com
NVS
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
prnewswire.com
NVS
AZN
Nasal Mucosa Therapeutics Market Forecast 2026-2036: Market to Reach USD 31.7 Billion by 2036 at 18.3% CAGR
accessnewswire.com
GSK
JNJ
PFE
AZN
APT
NVS
LLY
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
globenewswire.com
NVS